Daiwa Securities Group’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.7M Buy
156,584
+54,373
+53% +$4.53M 0.04% 277
2025
Q4
$7.81M Buy
102,211
+49,685
+95% +$3.81M 0.02% 361
2025
Q3
$4.18M Buy
52,526
+36,095
+220% +$2.7M 0.01% 487
2025
Q2
$1.15M Buy
16,431
+840
+5% +$61.5K ﹤0.01% 723
2025
Q1
$1.15M Buy
15,591
+620
+4% +$43.7K ﹤0.01% 705
2024
Q4
$1.04M Buy
14,971
+456
+3% +$34.7K ﹤0.01% 725
2024
Q3
$1.22M Buy
14,515
+1,027
+8% +$79.2K 0.01% 696
2024
Q2
$914K Sell
13,488
-597
-4% -$38.3K ﹤0.01% 725
2024
Q1
$885K Buy
14,085
+951
+7% +$53.6K 0.01% 734
2023
Q4
$734K Sell
13,134
-674
-5% -$35.7K ﹤0.01% 760
2023
Q3
$709K Buy
13,808
+483
+4% +$25.3K 0.01% 762
2023
Q2
$698K Buy
13,325
+73
+0.6% +$3.76K ﹤0.01% 751
2023
Q1
$684K Buy
13,252
+1,153
+10% +$62.9K ﹤0.01% 749
2022
Q4
$632K Sell
12,099
-352
-3% -$19.3K ﹤0.01% 754
2022
Q3
$704K Sell
12,451
-363
-3% -$22.9K 0.01% 728
2022
Q2
$777K Sell
12,814
-804
-6% -$45.8K 0.01% 720
2022
Q1
$804K Buy
13,618
+78
+0.6% +$4.44K 0.01% 754
2021
Q4
$778K Buy
13,540
+1,165
+9% +$64.5K ﹤0.01% 765
2021
Q3
$662K Buy
12,375
+854
+7% +$53.4K ﹤0.01% 779
2021
Q2
$772K Buy
11,521
+524
+5% +$36.5K 0.01% 725
2021
Q1
$795K Buy
10,997
+500
+5% +$34.9K 0.01% 695
2020
Q4
$726K Buy
10,497
+600
+6% +$38.1K 0.01% 661
2020
Q3
$596K Sell
9,897
-603
-6% -$37.2K 0.01% 645
2020
Q2
$520K Hold
10,500
0.01% 527
2020
Q1
$520K Sell
10,500
-2,700
-20% -$205K 0.01% 640
2019
Q4
$1.08M Buy
13,200
+2,300
+21% +$188K 0.01% 505
2019
Q3
$898K Buy
10,900
+3,700
+51% +$301K 0.01% 534
2019
Q2
$562K Buy
7,200
+200
+3% +$15.5K 0.01% 629
2019
Q1
$550K Buy
7,000
+300
+4% +$23.8K ﹤0.01% 615
2018
Q4
$506K Buy
6,700
+300
+5% +$22.6K ﹤0.01% 592
2018
Q3
$484K Buy
6,400
+600
+10% +$45.8K ﹤0.01% 663
2018
Q2
$427K Buy
5,800
+300
+5% +$21.2K ﹤0.01% 685
2018
Q1
$370K Buy
5,500
+900
+20% +$61.5K ﹤0.01% 703
2017
Q4
$347K Buy
4,600
+600
+15% +$46.6K ﹤0.01% 722
2017
Q3
$309K Buy
4,000
+400
+11% +$31.3K ﹤0.01% 703
2017
Q2
$285K Buy
3,600
+400
+13% +$30.3K ﹤0.01% 690
2017
Q1
$232K Buy
3,200
+55
+2% +$4.03K ﹤0.01% 751
2016
Q4
$234K Buy
3,145
+900
+40% +$66.1K ﹤0.01% 724
2016
Q3
$176K Buy
2,245
+200
+10% +$15.7K ﹤0.01% 716
2016
Q2
$153K Sell
2,045
-245
-11% -$17K ﹤0.01% 725
2016
Q1
$152K Buy
2,290
+1,090
+91% +$67.3K ﹤0.01% 729
2015
Q4
$73K Buy
1,200
+100
+9% +$5.96K ﹤0.01% 849
2015
Q3
$63K Hold
1,100
﹤0.01% 856
2015
Q2
$69K Hold
1,100
﹤0.01% 887
2015
Q1
$78K Buy
1,100
+100
+10% +$7.22K ﹤0.01% 820
2014
Q4
$70K Buy
1,000
+100
+11% +$6.5K ﹤0.01% 811
2014
Q3
$51K Buy
900
+100
+13% +$6.2K ﹤0.01% 826
2014
Q2
$50K Buy
800
+100
+14% +$6.17K ﹤0.01% 814
2014
Q1
$42K Hold
700
﹤0.01% 819
2013
Q4
$39K Hold
700
﹤0.01% 813
2013
Q3
$40K Hold
700
﹤0.01% 826
2013
Q2
$42K Buy
+700
New +$45.3K ﹤0.01% 824

Other funds holding NHI

Daiwa Securities Group's NHI Position: Q1 2026 in Review

Daiwa Securities Group increased its National Health Investors (NHI) stake by 53% in Q1 2026, buying an estimated $4.53M and bringing the position to 156,584 shares worth $12.7M. The position accounts for 0.04% of the portfolio, ranked #277.

Daiwa Securities Group first reported a position in NHI in Q2 2013 and has held it in 52 quarters since. 318 funds tracked by Wall St. Rank hold NHI as of Q1 2026.

  • Daiwa Securities Group held 156,584 shares of National Health Investors worth $12.7M as of Q1 2026.
  • Daiwa Securities Group bought 54,373 National Health Investors shares in Q1 2026, an estimated $4.53M.
  • National Health Investors made up 0.04% of Daiwa Securities Group's portfolio in Q1 2026, its #277 holding.
  • Daiwa Securities Group first reported a position in National Health Investors in Q2 2013 and has held it in 52 quarters since.
  • 318 funds tracked by Wall St. Rank held National Health Investors as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.